A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) (MVOR-2)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05343455 |
|
Recruitment Status :
Completed
First Posted : April 25, 2022
Last Update Posted : August 2, 2023
|
Sponsor:
Journey Medical Corporation
Collaborator:
Dr. Reddy's Laboratories Limited
Information provided by (Responsible Party):
Journey Medical Corporation
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 30, 2023 |
| Actual Study Completion Date : | June 30, 2023 |